Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
| Image |  |
|---|---|
| Description | scientific article published on 14 February 2014 |
| Author/s |
author: Hans D Menssen Gianantonio Rosti François Guilhot Philipp le Coutre Hagop Kantarjian Gert J Ossenkoppele Dietger Niederwieser Richard A. Larson Giuseppe Saglio Andreas Hochhaus |
| Publication date | February 14, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |